Search research articles
Contact Us
Filters
Showing results (81-90 of 268) with videos related to
Page
of 27
Sort By:
Neurology
|
February 25, 2011
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
J Kuhle, D Leppert, A Petzold, et al.
Neurology
|
September 27, 2006
CSF neurofilament levels: a potential prognostic marker in Guillain-Barré syndrome
A Petzold, N Hinds, N M F Murray, et al.
Neurology
|
October 1, 2010
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency
V Worthington, J Killestein, M J Eikelenboom, et al.
Plos One
|
July 17, 2018
A standardized protocol for quantification of saccadic eye movements: DEMoNS
J A Nij Bijvank, A Petzold, L J Balk, et al.
Vision Research
|
February 18, 2020
Saccadic delay in multiple sclerosis: A quantitative description
J A Nij Bijvank, A Petzold, D Coric, et al.
Neuroscience Letters
|
December 31, 2002
Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease
A Petzold, R Jenkins, H C Watt, et al.
Journal of the Neurological Sciences
|
June 3, 2019
Saccadic fatigability in the oculomotor system
J A Nij Bijvank, L J van Rijn, M Kamminga, et al.
Molecular Diagnosis & Therapy
|
July 3, 2014
Effects of repeated intrathecal triamcinolone-acetonide application on cerebrospinal fluid biomarkers of axonal damage and glial activity in multiple sclerosis patients
P S Rommer, F Kamin, A Petzold, et al.
Muscle & Nerve
|
June 18, 2009
CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome
A Petzold, J Brettschneider, K Jin, et al.
European Journal of Neurology
|
July 26, 2019
Objective quantification of vitreous haze on optical coherence tomography scans: no evidence for relationship between uveitis and inflammation in multiple sclerosis
D Coric, G Ometto, G Montesano, et al.
Page
of 27
Search research articles
Search
Showing results (81-90 of 268) with videos related to
Sort By:
Page
of 27
Neurology
|
February 25, 2011
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
J Kuhle, D Leppert, A Petzold, et al.
Neurology
|
September 27, 2006
CSF neurofilament levels: a potential prognostic marker in Guillain-Barré syndrome
A Petzold, N Hinds, N M F Murray, et al.
Neurology
|
October 1, 2010
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency
V Worthington, J Killestein, M J Eikelenboom, et al.
Plos One
|
July 17, 2018
A standardized protocol for quantification of saccadic eye movements: DEMoNS
J A Nij Bijvank, A Petzold, L J Balk, et al.
Vision Research
|
February 18, 2020
Saccadic delay in multiple sclerosis: A quantitative description
J A Nij Bijvank, A Petzold, D Coric, et al.
Neuroscience Letters
|
December 31, 2002
Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease
A Petzold, R Jenkins, H C Watt, et al.
Journal of the Neurological Sciences
|
June 3, 2019
Saccadic fatigability in the oculomotor system
J A Nij Bijvank, L J van Rijn, M Kamminga, et al.
Molecular Diagnosis & Therapy
|
July 3, 2014
Effects of repeated intrathecal triamcinolone-acetonide application on cerebrospinal fluid biomarkers of axonal damage and glial activity in multiple sclerosis patients
P S Rommer, F Kamin, A Petzold, et al.
Muscle & Nerve
|
June 18, 2009
CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome
A Petzold, J Brettschneider, K Jin, et al.
European Journal of Neurology
|
July 26, 2019
Objective quantification of vitreous haze on optical coherence tomography scans: no evidence for relationship between uveitis and inflammation in multiple sclerosis
D Coric, G Ometto, G Montesano, et al.
Page
of 27